SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported net income of $27.9 million in its third quarter.
On a per-share basis, the South San Francisco, California-based company said it had profit of $1.46.
The drug developer posted revenue of $69.5 million in the period.
Rigel expects full-year revenue in the range of $285 million to $290 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RIGL at https://www.zacks.com/ap/RIGL
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
